Englander Institute for Precision Medicine

Events

May
23
3:00pm - 4:00pm Belfer Research Building
Englander Institute for Precision Medicine - Journal Club Discussion Article: Towards a general-purpose foundation model for computational pathology Presented By: Mohamed Omar, M.D. Assistant Professor of Research Department of Pathology and Laboratory Medicine Weill Cornell Medicine
screenshot of article on Nature Medicine's website
Jun
06
12:00pm - 1:00pm Belfer Research Building
We leverage patient-derived 3D organoid models from different cancers, which reproduce the oncogenic programs of human tumors, to reveal cellular and molecular mechanisms underlying tumor-intrinsic sensitivity to IFNg. The talk will address: How intratumoral genetic heterogeneity influences sensitivity to IFNg signaling.How intratumoral genetic heterogeneity influences the expression of IFNg-induced and therapeutically relevant immune checkpoints and soluble mediators. Such insights are key to the development of combination treatments targeting immune checkpoint ligands and tumor-specific vulnerabilities.Given the critical role of IFNg in antitumor immunity, we address how tissue-specific and tumor-intrinsic differences must be considered to identify targetable immunophenotypes and underlying molecular cascades that influence IFNg responsivity and ICB efficacy.About Dr. Anna S. Tocheva: My laboratory integrates cellular and molecular immunological assays with high-throughput proteomic and genomic approaches to study the signaling pathways triggered by immune checkpoints in human T cells. In parallel, we develop scalable approaches that incorporate cancer patient-derived organoids with reconstituted immune cells allowing us to translate these fundamental immunobiology discoveries into functional pre-clinical immunoassays to identify mono- and combination immunotherapies that augment anti-tumor T cell responses. — Anna S. Tocheva, Ph.D. Assistant Professor Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai
Anna S. Tocheva
Jun
18
11:00am - 12:00pm WCMC Campus
Anne O’Donnell Luria, M.D., Ph.D. Co-Director of the Center for Mendelian Genomics (CMG) at the Broad Institute of MIT and Harvard Attending Physician in Genetics and Metabolism, Boston Children’s Hospital Assistant Professor, Harvard Medical School Presenting "Navigating the Unknown: Novel Approaches to Rare Disease Diagnosis.”
Anne O’Donnell Luria

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021